Clinton Foundation HIV Drugs to Africa: Watered Down

Congressional Report: "Clinton Foundation & The India Success Story" -- Bill Clinton's Foundation (CHAI) gave "watered-down" HIV/AIDs drugs to patients in sub-Saharan Africa

​9-19-16, Daily Caller -- [Excerpt] According to a draft of the US Congressional report, the medicine for HIV/Aids supplied to African patients by the Clinton Foundation was 'watered down' and “likely increased” the risks of death. The Clinton Health Access Initiative [CHAI] program to help AIDS victims in Africa has been considered one of the Clinton’s most important contributions and is probably its best known initiative. The report focused on Clinton’s decade-long relationship with a controversial Indian drug manufacturer called Ranbaxy, which CHAI used as one of its main distributors of HIV/AIDS drugs to Third World countries.

A whistleblower employee, Dinesh Thakur, of Ranbaxy became a star witness, permitting the U.S. government to launch a landmark lawsuit against the Indian firm. The company was vulnerable to U.S. prosecution because it also sold its generic drugs on the U.S. market. Ranbaxy ultimately pleaded guilty in 2013 to seven criminal counts with intent to defraud and the introduction of adulterated drugs into interstate commerce.

---

7-14-07, NY Times 
It's gone now, but Hillary Clinton's image was featured with the Gupta's on their website; see the screen shot: ​

---

The Dept of Justice said the drugs were diluted and further levied a $500 million fine. “This is the largest false claims case ever prosecuted in the District of Maryland, and the nation’s largest financial penalty paid by a generic pharmaceutical company,” said U.S. Attorney for the District of Maryland Rod J. Rosenstein.

Ranbaxy’s first public hint of problems occurred in August 2004, one year after CHAI began working with the firm. The World Health Organization reported irregularities involving three Ranbaxy drugs in South Africa, according to the report.

The FDA sent a public “warning letter” to Ranbaxy in 2006 about reported irregularities in the company’s quality control efforts. It concluded that the drugs, which included anti-retroviral HIV/AIDs medications, “show much lower potencies in these batches.”

One relationship unearthed by the report was the American Indian Foundation, which Clinton co-founded with Indian-American businessmen Rajat Gupta and Vinod Gupta in 2001.

• Rajat was convicted of insider trading in 2012 in a sensational trial.
• Vinod eventually was forced to resign as CEO and chairman of the company InfoGroup and was fined $9 million in a Securities and Exchange Commission investigation.
• Vinod was charged that he had awarded Bill Clinton $3.3 million without board approval.

The possibility that Clinton's CHAI distributed adulterated and diluted AIDS drugs to Third World victims could shake the foundations of the Clinton charity and spark a new round of scrutiny in the final weeks of presidential candidate Hillary Clinton’s campaign.

In 2013 Bill Clinton heaped praise on Ranbaxy during a speech in Mumbai, saying, the drugs saved millions of lives. Neither CHAI nor the Clinton Foundation have announced they severed ties with Ranbaxy.*

More: http://dailycaller.com/2016/09/19/exclusive-clinton-foundation-aids-program-distributed-watered-down-drugs-to-third-world-countries/#ixzz4Kr6VDEhJ 
****

2007: New York Times, When former President Bill Clinton and Senator Clinton took a family vacation in January 2002 to Acapulco, Mexico, one of their longtime supporters, Vinod Gupta, provided his company’s private jet to fly them there. 

Court records show that the company, infoUSA, one of the nation’s largest brokers of information on consumers, paid $146,866 to ferry the Clintons, Mr. Gupta and others to Acapulco and back. During the next four years, infoUSA paid Mr. Clinton more than $2 million for consulting services, and spent almost $900,000 to fly him around the world for his presidential foundation work and to fly Mrs. Clinton to campaign events. 
http://www.nytimes.com/2007/05/26/us/politics/26clinton.html?_r=0
***

* Note: In 2014, Sun Pharma acquired the entire 63.4% share of Ranbaxy making the conglomerate the world’s fifth largest specialty generic pharma company. 
https://en.wikipedia.org/wiki/Ranbaxy_Laboratories